Clinical studies recruiting near Qingdao

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · The Affiliated Hospital of Qingdao University · Bristol-Myers Squibb · NCT07106762 Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Phase 2 · The Affiliated Hospital of Qingdao University · Guangdong Association of Clinical Trials · NCT05536505 Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
Phase 4 · Affiliated Hospital of Qingdao University · Shandong First Medical University · NCT06171061 Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
Phase N/A · The Affiliated Hospital of Qingdao University · The Affiliated Hospital of Qingdao University · NCT06916338 The Chinese Familial Alzheimer's Network
Phase N/A · Qilu Hospital of Shandong University (Qingdao) · Capital Medical University · NCT03657732 Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Phase 2 · Qingdao Central Hospital, The Second Affiliated Hospital of · Shandong University · NCT06251947 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · The Affiliated Hospital of Qingdao University · Eli Lilly and Company · NCT07415044 Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Phase 3 · The Affiliated Hospital of Qingdao University · The Affiliated Hospital of Qingdao University · NCT05871099 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese
Phase 3 · Qingdao Eye Hospital of Shandong First Medical University · Hoffmann-La Roche · NCT05562947 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · The Affiliated Hospital of Qingdao University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
Phase N/A · The Affiliated Hospital of Qingdao University · Shanghai Chest Hospital · NCT07541521 Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Phase 2 · The Affiliated Hospital of Qingdao University · Zhejiang Provincial People's Hospital · NCT05446467 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
Phase N/A · The Affiliated Hospital of Medical College of Qingdao Univer · Chinese University of Hong Kong · NCT05578300 A Study of HS-20094 in Overweight or Obese Participants
Phase 1 · The Affiliated Hospital of Qingdao University · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT07057674 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0169 · Celgene · NCT05519085 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no O
Phase 3 · Qingdao Women and Children's Hospital · Actelion · NCT05179876 Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)
NA · The Affiliated Hospital Of Qingdao University · Hangzhou Endonom Medtech Co., Ltd. · NCT06385379 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Qingdao Cardiovascular Hospital · Boehringer Ingelheim · NCT06531824 A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation
NA · Affiliated Hospital of Qingdao University · The Affiliated Hospital of Qingdao University · NCT07250581 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · The Affiliated Hospital of Qingdao University - Xihaian Camp · Biogen · NCT06962800 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · The Affiliated Hospital of Qingdao University · Antengene Biologics Limited · NCT07327229 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Qingdao Municipal Hospital · Peking Union Medical College Hospital · NCT05866029 Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NA · The Affiliated Hospital of Qingdao University · Sun Yat-sen University · NCT06524427 JS207 Combination Therapy in Triple-negative Breast Cancer
Phase 2 · The Affiliated Hospital of Qingdao University · Shanghai Junshi Bioscience Co., Ltd. · NCT07045311 Real-world Study of Aflibercept 8 mg in nAMD
Phase N/A · Qingdao Eye Hospital Of Shandong First Medical University · Peking University People's Hospital · NCT07640997 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che
Phase 3 · The Affiliated Hospital Of Medical College Qingdao Universit · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · The Affiliated Hospital of Qingdao University · Fudan University · NCT04790305 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Qingdao Municipal Hospital (Group) · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Wit
Phase 1/Phase 2 · Qingdao University Hospital · Bambusa Therapeutics · NCT07436949

Look up another city

Look up another condition